Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia

Keyphrases

• Aberrant Expression 20%
• Cancer Types 20%
• CEBPA 20%
• Cellular Processes 20%
• Clinically Significant 20%
• Cytogenetically Normal 20%
• Differentially Expressed mRNAs (DEmRNAs) 100%
• Expression Pattern 20%
• FLT3-ITD 40%
• Gene Expression 20%
• High-level Expression 20%
• HOXA Genes 20%
• HOXB Genes 20%
• Leukemia Patients 20%
• Low Expression 20%
• MicroRNA 80%
• MicroRNA-155 (miR-155) 40%
• MiR-196a 60%
• MiR-29a 40%
• MiRNA Expression 20%
• MLL Gene Rearrangement 20%
• Molecular Subgroups 40%
• Molecular Subtypes 100%
• NPM1 mutation 20%
• Nucleophosmin 1 (NPM1) 20%
• Pediatric Leukemia 100%
• Quantitative PCR 20%
• Spearman 20%
• Stem-loop 20%

Biochemistry, Genetics and Molecular Biology

• CCAAT Enhancer Binding Protein Alpha 20%
• Cytogenetics 100%
• Gene Expression 20%
• Gene Rearrangement 20%
• MicroRNA 20%
• MiR-155 40%
• Myeloid 100%
• NPM1 40%
• Quantitative Reverse Transcription Polymerase Chain Reaction 20%
• Stem-Loop 20%

Medicine and Dentistry

• CCAAT Enhancer Binding Protein Alpha 16%
• Gene Expression 16%
• Gene Rearrangement 16%
• Malignant Neoplasm 16%
• microRNA 100%
• microRNA 155 33%
• microRNA 29a 33%
• NPM1 33%
• Pediatric Acute Myeloid Leukemia 100%
• Quantitative Reverse Transcription Polymerase Chain Reaction 16%